During Tuesday’s afternoon trade, Shares of American Airlines Group Inc. (NASDAQ:AAL), lost -1.72% to $39.38.
American Airlines to delay purchase of some Airbus Jetliners, according to WSJ.
American Airlines Group, said it reached a contract to defer the purchase of 35 Airbus A320 single-aisle jetliners, a move the carrier said will give it more flexibility in 2017 and 2018. WSJ Reports.
American Airlines Group Inc., through its auxiliaries, operates in the airline industry. As of December 31, 2014, the company operated 983 mainline jets, in addition to 566 regional aircrafts through regional airline auxiliaries and third-party regional carriers. It serves 339 destinations in 54 countries.
Shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), inclined 3.97% to $11.15, during its current trading session.
ZIOPHARM Oncology, declared that Caesar J. Belbel, Executive Vice President, Chief Legal Officer and Secretary, has been designated to the added role of Chief Operating Officer, effective right away.
“Caesar has been an integral part of the ZIOPHARM senior administration team through the Company’s evolution into a leading developer of next generation immuno-oncology therapeutics,” said Laurence J. N. Cooper, M.D., Ph.D., Chief Executive Officer of ZIOPHARM. “He has the experience and expertise, developed over a 30 year career in advising and building emerging companies, to assist ZIOPHARM prosper in its next phase of development. We expect that his leadership, corporate development and transactional experience will continue to add noteworthy value to the Company as he takes on the responsibilities of this new role.”
ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in partnership with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability.
Finally, Southern Company (NYSE:SO), gained 0.84%, and is now trading at $42.45.
For the fifth year in a row, Georgia Power is joining with other energy companies, auto manufacturers and Commissioner Tim Echols of the Georgia Public Service Commission (PSC) to support the Georgia Alternative Fuel Vehicle (AFV) Roadshow. The AFV Roadshow, kicking off recently in Gainesville, is an annual cross-state event focused on showcasing clean transportation options, counting electric vehicles (EVs). During this year’s roadshow, Georgia Power is highlighting its electric transportation program counting EV charger rebates for residential and business customers and new public charging infrastructure presently being installed across the state.
Since its creation in 2011, the AFV Roadshow has become a national event with tours reaching dozens of cities in seven states. Local educational events as part of the tour are designed to equip fleet managers, city leaders and state legislators with the information they need to make informed decisions about transitioning to domestic, clean fuels. The roadshow incorporates vehicle demos in addition to live, educational seminars.
Georgia Power is the largest partner of Southern Company (NYSE: SO), one of the nation’s largest generators of electricity. Value, Reliability, Customer Service and Stewardship form the cornerstones of the company’s promise to 2.4 million customers in all but four of Georgia’s 159 counties.
The Southern Company, together with its auxiliaries, operates as a public electric utility company. It is involved in the generation, transmission, and distribution of electricity through coal, nuclear, oil and gas, and hydro resources in the states of Alabama, Georgia, Florida, and Mississippi.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
